RYMTI
Google image searchProduct monograph
Active ingredient
etanercept, 50 MG/1 ML
DIN: 02530295
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: 1 ML SINGLE-USE PRE-FILLED SYRINGE
Schedule: Prescription / Schedule D
Company: LUPIN PHARMA CANADA LIMITED
Date: 05-APR-2024
ATC:
- L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
- L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
- L04AB — Tumor necrosis factor alpha (TNF-alpha) inhibitors (ATC, ATC/DDD)
- L04AB01 — ETANERCEPT (ATC/DDD)
Reference brand drug: Enbrel
Pharmaceutical standard: MFR
